Roche

NextHealth PHL

Why the $4.3 Billion Spark Therapeutics Deal Is Still Delayed

This week, Swiss multinational healthcare company Roche announced yet another delay in the company’s intended $4.3 billion acquisition of Philadelphia-based gene therapy company¬†Spark Therapeutics. Spark […]